Potentiating TRPA1 by Sea Anemone Peptide Ms 9a-1 Reduces Pain and Inflammation in a Model of Osteoarthritis
Marine Drugs · 28.11.2023 · 21 (12) · 617
DOI: 10.3390/md21120617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 28.11.2023. Verfasst von Ekaterina E Maleeva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia. Hauptthemen laut MEDLINE: Sea Anemones, Osteoarthritis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Progressive articular surface degradation during arthritis causes ongoing pain and hyperalgesia that lead to the development of functional disability. TRPA1 channel significantly contributes to the activation of sensory neurons that initiate neurogenic inflammation and mediates pain signal transduction to the central nervous system. Peptide Ms 9a-1 from the sea anemone Metridium senile is a positive allosteric modulator of TRPA1 and shows significant anti-inflammatory and analgesic activity in different models of pain. We used a model of monosodium iodoacetate (MIA)-induced osteoarthritis to evaluate the anti-inflammatory properties of Ms 9a-1 in comparison with APHC3 (a polypeptide modulator of TRPV1 channel) and non-steroidal anti-inflammatory drugs (NSAIDs) such as meloxicam and ibuprofen. Administration of Ms 9a-1 (0.1 mg/kg, subcutaneously) significantly reversed joint swelling, disability, thermal and mechanical hypersensitivity, and grip strength impairment. The effect of Ms 9a-1 was equal to or better than that of reference drugs. Post-treatment histological analysis revealed that long-term administration of Ms9a-1 could reduce inflammatory changes in joints and prevent the progression of cartilage and bone destruction at the same level as meloxicam. Peptide Ms 9a-1 showed significant analgesic and anti-inflammatory effects in the model of MIA-induced OA, and therefore positive allosteric modulators could be considered for the alleviation of OA symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia.
- Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Prospekt Nauki, 6, 142290 Pushchino, Russia.
- Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya Str. 8, Bld. 2, 119991 Moscow, Russia.
ORCID-Profile: Yulia A Palikova, Viktor A Palikov, Nadezhda V Tarasova, Igor A Dyachenko, Yaroslav A Andreev
Förderung
- Russian Science Foundation
Zitieren
APA
Maleeva, E. E., Palikova, Y. A., Palikov, V. A., Kazakov, V. A., Simonova, M. A., Logashina, Y. A., Tarasova, N. V., Dyachenko, I. A., & Andreev, Y. A. (2023). Potentiating TRPA1 by Sea Anemone Peptide Ms 9a-1 Reduces Pain and Inflammation in a Model of Osteoarthritis. Marine Drugs, 21(12), 617. https://doi.org/10.3390/md21120617
Vancouver
Maleeva EE, Palikova YA, Palikov VA, Kazakov VA, Simonova MA, Logashina YA, et al. Potentiating TRPA1 by Sea Anemone Peptide Ms 9a-1 Reduces Pain and Inflammation in a Model of Osteoarthritis. Marine Drugs. 2023;21(12):617. doi:10.3390/md21120617
BibTeX
@article{Maleeva2023,
author = {Maleeva, Ekaterina E and Palikova, Yulia A and Palikov, Viktor A and Kazakov, Vitaly A and Simonova, Maria A and Logashina, Yulia A and Tarasova, Nadezhda V and Dyachenko, Igor A and Andreev, Yaroslav A},
title = {Potentiating TRPA1 by Sea Anemone Peptide Ms 9a-1 Reduces Pain and Inflammation in a Model of Osteoarthritis},
journal = {Marine Drugs},
year = {2023},
volume = {21},
number = {12},
pages = {617},
doi = {10.3390/md21120617}
}
EUVIMED